Status: Not yet recruiting
Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD
Phase 1/2 Study of KRRO-121 is a randomized, placebo-controlled study in Healthy Volunteers (Phase 1 SAD and MAD) and Study Participants with Urea Cycle Disorders (Phase 2). The primary objective of the study is to evaluate the safety of KRRO-121.
Participants needed: 30
Trial details
Phase: Phase 1, Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Korro Bio, Inc.Updated: Aug 20, 2026Locations: 1
Eligibility criteria
Adult male or female participants, 18 to 65 years of age [+3]
Any medical history that is clinically significant in the opinion of the Princip... [+4]